A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease

被引:119
作者
Grove, Erik Lerkevang [1 ]
Hvas, Anne-Mette [2 ]
Johnsen, Helle Ladefoged [1 ]
Hedegaard, Sofie Sommer [1 ]
Pedersen, Susanne Bendesgaard [1 ]
Mortensen, Jette [1 ]
Kristensen, Steen Dalby [1 ]
机构
[1] Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Clin Biochem, DK-8200 Aarhus, Denmark
关键词
Aspirin; aspirin resistance; cardiology; platelet function tests; thromboxanes; LIGHT TRANSMISSION AGGREGOMETRY; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; POSITION PAPER; WORKING GROUP; RISK-FACTORS; WHOLE-BLOOD; RESISTANCE; AGGREGATION;
D O I
10.1160/TH09-08-0527
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Individualised antiplatelet therapy and platelet function testing have attracted considerable clinical interest, but several aspects of test performance have not been thoroughly evaluated, We investigated repeatability and concordance of light transmission aggregometry (LTA) induced with arachidonic acid (AA) 1.0 mM, PFA-100((R)) induced with collagen/epinephrine, multiple electrode aggregometry (MEA) induced with AA 0.5 or 0.75 mM and VerifyNow((R)) Aspirin. Patients with stable coronary artery disease (n=43) and healthy individuals (n=21) were included. All tests were performed in duplicate at baseline in healthy individuals and in duplicate for four days in all study participants during aspirin treatment. Serum and urinary thromboxane metabolites were measured several times to evaluate cyclooxygenase-1 inhibition by aspirin. MEA was most sensitive for aspirin as treatment induced a 12-fold difference in AA-induced platelet aggregation. Coefficients of variation for duplicate measurements at baseline (0.4-12%), during aspirin treatment (3-46%) and for day-to-day variability (3-37%) differed markedly between tests and were lowest for VerifyNow((R)). The prevalence of aspirin low-responsiveness also differed between tests (0-9%) and the agreement was low: kappa <= 0.21 for all tests compared with AA-induced LTA (reference test), which correlated best with VerifyNow((R)) (r=0.43, p<0.001). Urinary thromboxane metabolites did not correlate with any platelet function test, whereas serum thromboxane correlated with VerifyNow((R)) Aspirin (r=0.41, p=0.001). Overall, repeatability was moderate and the correlation between tests was low. VerifyNow((R)) Aspirin proved most reproducible, and this was the only assay showing a significant positive correlation with serum thromboxane. This study demonstrated that conclusions based on platelet function testing strongly depend on the assay used.
引用
收藏
页码:1245 / 1253
页数:9
相关论文
共 47 条
[31]   Assessment of aspirin resistance varies on a temporal basis in patients with ischaemic heart disease [J].
Muir, A. R. ;
McMullin, M. F. ;
Patterson, C. ;
McKeown, P. P. .
HEART, 2009, 95 (15) :1225-1229
[32]   Assessment of platelet function assays [J].
Nicholson, NS ;
Panzer-Knodle, SG ;
Haas, NF ;
Taite, BB ;
Szalony, JA ;
Page, JD ;
Feigen, LP ;
Lansky, DM ;
Salyers, AK .
AMERICAN HEART JOURNAL, 1998, 135 (05) :S170-S178
[33]   Aspirin response evaluated by the VerifyNow™ Aspirin System and Light Transmission Aggregometry [J].
Nielsen, Helle L. ;
Kristensen, Steen D. ;
Thygesen, Sofie S. ;
Mortensen, Jette ;
Pedersen, Susanne B. ;
Grove, Erik L. ;
Hvas, Anne-Mette .
THROMBOSIS RESEARCH, 2008, 123 (02) :267-273
[34]   Comparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatment [J].
Paniccia, Rita ;
Antonucci, Emilia ;
Gori, Anna Maria ;
Marcucci, Rossella ;
Poli, Serena ;
Romano, Eloisa ;
Valente, Serafina ;
Giglioli, Cristina ;
Fedi, Sandra ;
Gensini, Gian Franco ;
Abbate, Rosanna ;
Prisco, Domenico .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 128 (01) :143-149
[35]   ESTIMATED RATE OF THROMBOXANE SECRETION INTO THE CIRCULATION OF NORMAL HUMANS [J].
PATRONO, C ;
CIABATTONI, G ;
PUGLIESE, F ;
PIERUCCI, A ;
BLAIR, IA ;
FITZGERALD, GA .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (02) :590-594
[36]   Evaluation of aspirin response by Multiplate® whole blood aggregometry and light transmission aggregometry [J].
Pedersen, Susanne B. ;
Grove, Erik L. ;
Nielsen, Helle L. ;
Mortensen, Jette ;
Kristensen, Steen D. ;
Hvas, Anne-Mette .
PLATELETS, 2009, 20 (06) :415-420
[37]   Dose- and time-dependent antiplatelet effects of aspirin [J].
Perneby, C ;
Wallén, NH ;
Rooney, C ;
Fitzgerald, D ;
Hjemdahl, P .
THROMBOSIS AND HAEMOSTASIS, 2006, 95 (04) :652-658
[38]   Using the Platelet Function Analyzer-100 for monitoring aspirin therapy [J].
Poulsen, Tina Svenstrup ;
Mickley, Hans ;
Korsholm, Lars ;
Licht, Peter Bjorn ;
Haghfelt, Torben ;
Jorgensen, Bo .
THROMBOSIS RESEARCH, 2007, 120 (02) :161-172
[39]   Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment [J].
Sibbing, Dirk ;
Braun, Siegmund ;
Jawansky, Stefan ;
Vogt, Wolfgang ;
Mehilli, Julinda ;
Schoemig, Albert ;
Kastrati, Adnan ;
von Beckerath, Nicolas .
THROMBOSIS AND HAEMOSTASIS, 2008, 99 (01) :121-126
[40]   Cross validation of the Multiple Electrode Aggregometry A prospective trial in healthy volunteers [J].
Siller-Matula, Jolanta M. ;
Gouya, Ghazaleh ;
Wolzt, Michael ;
Jilma, Bernd .
THROMBOSIS AND HAEMOSTASIS, 2009, 102 (02) :397-403